Cargando…
Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes
Type 1 diabetes (T1D) results from the destruction of pancreatic beta cells through a process that is primarily mediated by T cells. Emerging evidence suggests that dendritic cells (DCs) play a crucial role in initiating and developing this debilitating disease. DCs are professional antigen-presenti...
Autores principales: | Khan, Farhan Ullah, Khongorzul, Puregmaa, Raki, Ahmed Aziz, Rajasekaran, Ashwini, Gris, Denis, Amrani, Abdelaziz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099521/ https://www.ncbi.nlm.nih.gov/pubmed/35563276 http://dx.doi.org/10.3390/ijms23094885 |
Ejemplares similares
-
Elucidating the Role of Ezh2 in Tolerogenic Function of NOD Bone Marrow-Derived Dendritic Cells Expressing Constitutively Active Stat5b
por: Zerif, Echarki, et al.
Publicado: (2020) -
Type 1 Diabetes Immunological Tolerance and Immunotherapy
por: Chentoufi, Aziz Alami, et al.
Publicado: (2011) -
NLRX1 Enhances Glutamate Uptake and Inhibits Glutamate Release by Astrocytes
por: Mahmoud, Shaimaa, et al.
Publicado: (2019) -
Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis
por: Liu, Caiyun, et al.
Publicado: (2022) -
NLR-Dependent Regulation of Inflammation in Multiple Sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2018)